Color Genomics

color.com →

-34%

est. 2Y upside i

HealthcareSeries D+

Color provides the technology and infrastructure for large-scale health initiatives, from population genomics programs to high throughput COVID-19 testing.

Rank

#3523

Sector

HealthTech

Est. Liquidity

~3Y

Data Quality

Data: Low

Equity compensation at Color is high risk with negative expected upside over 2 years.

Last updated: July 3, 2026

Bull (10%)+72%

Expansion of partnerships and ASCO certification drive market share, leading to an 8x exit multiple on projected 2028 revenue of $303M, implying a $2.4B exit. After preference and dilution, common stock yields 71.5% upside.

Base (50%)-19%

Revenue growth moderates to 15% annually, exit multiple converges to 5x, yielding $1.5B exit. Preference overhang and dilution result in a slight negative return for common shareholders.

Bear (40%)-79%

Incumbent competition from Labcorp, Quest, and Epic intensifies, compressing exit multiple to 3x on $303M revenue. Exit of $909M barely covers preference, leaving common stock with a -78.6% return after dilution.

Est. time to liquidity~3.0 years

Preference Stack Risk

severe

Funding Intensity

3270%

Total funding of $491M represents 32.7% of the current valuation, creating a significant liquidation preference overhang.

Dilution Risk

high

Without profitability, the company may need to raise additional capital, diluting existing shareholders by an estimated 15-25% in the next 2 years.

Secondary Liquidity

limited

A secondary market exists but has experienced significant valuation declines; liquidity is limited and not guaranteed.

Other — 3 roles

View all 3 open roles at Color Genomics →

Last updated: February 22, 2026

Questions to Ask at the Interview

Strategic questions based on Color Genomics's data — designed to show you've done your homework.

  • 1

    “How does Color differentiate from Labcorp and Quest's testing services?”

  • 2

    “What is the path to profitability and cash flow breakeven?”

  • 3

    “Given the recent secondary valuation drop, how does the company plan to restore investor confidence?”

Community

Valuation Sentiment

Our model estimates -34% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.